Mercury

Mercury Bio is a biotechnology company specializing in next-generation biomolecular drug delivery through its proprietary yEV™ platform. The technology utilizes engineered yeast-derived extracellular vesicles to encapsulate and transport therapeutic payloads, including RNA, proteins, and nanobodies, directly into targeted cells. This approach is designed to overcome traditional delivery barriers such as the blood-brain barrier and immune system clearance. The company's internal development focus is on neurodegenerative diseases like Alzheimer's and Parkinson's under its MB-TIP™ (Targeting Intracellular Pathologies) framework. Mercury Bio also collaborates with partners like Frame Bio to apply its delivery technology to regenerative medicine, including bone and collagen restoration.